DNPUF

Healthcare Drug Manufacturers - Specialty & Generic

Sumitomo Pharma Co., Ltd.

$9.79

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

4.39B

Avg Volume

P/E (TTM)

5.73

EPS

$1.71

52W High

$19.20

52W Low

$8.41

Div. Yield

0.0%

Valuation

P/B Ratio

1.69

P/S Ratio

0.01

EV/EBITDA

1.29

EV/Revenue

0.19

Margins

Gross Margin 55.0%

Operating Margin 13.7%

Net Margin 23.7%

EBITDA Margin 14.4%

Growth & Returns

Revenue Growth (YoY)

19.9%

Earnings Growth (YoY)

38.3%

Earnings Growth (QoQ)

51.7%

Return on Equity

38.5%

Return on Assets

3.9%

Liquidity & Leverage

Current Ratio

1.21

Quick Ratio

0.84

Debt / Equity

0.39

Total Cash

76.64B

Total Debt

160.66B

About

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.